Geron Corp. research and ratings by Barron's. View GERN revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.Geron Corporation Announces Pricing of $198 Million Upsized Public Offering of Common Stock and Pre-Funded Warrants. (Business Wire) -22.26%. Jan-04-23 04:19PM. Geron Corporation Announces Proposed Public Offering of Common Stock. (Business Wire) +32.92%. Geron plans to offer and sell $175 million shares of common stock with underwriters getting an option to buy an additional 15% of the undetermined number of shares available in the offering.Jan 24, 2023 · With a redemption price of $10.05 per share and a stock price of $10.14 per share, there is little downside risk. On the flip side, if shareholders vote for the extension, ABG could soon lock down ... GERN is on a pretty nice upswing, almost 29% YTD and about 56% for the past 12 months. I've owned this stock long enough to know this could be a short set up for some near term gains but the volume is such it seems like something else is afoot..... Well, I'm up $1,250 on this baby after today's rally. With a redemption price of $10.05 per share and a stock price of $10.14 per share, there is little downside risk. On the flip side, if shareholders vote for the extension, ABG could soon lock down ...Geron Corp. Annual stock financials by MarketWatch. View the latest GERN financial statements, income statements and financial ratios.Aug 13, 2021 · Well you can still buy a used Yugo. Kick the turds 💩 out of the way as you swirl down into the septic tank of penny stock investments. Hey buyMCD they still sell billions of happy meals plus you get a toyCheeseCracker, published August 13, 2021 What Else are GERN Traders Talking About? Other tickers frequently mentioned alongside GERN is SESN. Jan 4, 2023 · bankrx/iStock via Getty Images. 2023 has arrived. The year has started well, with Geron Corporation ( NASDAQ: GERN) producing superb data, data that makes imetelstat approvable after over a decade ... Geron Corp. advanced stock charts by Barron's. View GERN historical stock data and compare to other stocks, and exchanges.Geron Corporation ( GERN) is around the top of the Healthcare sector according to InvestorsObserver . GERN received an overall rating of 97, which means that it scores higher than 97% of stocks. Additionally, Geron Corporation scored a 99 in the Healthcare sector, ranking it higher than 99% of stocks in that sector.Geron Corp. options data by MarketWatch. View GERN option chain data and pricing information for given maturity periods.Stock Price Forecast. The 6 analysts offering 12-month price forecasts for Geron Corp have a median target of 5.00, with a high estimate of 6.00 and a low estimate of 4.00. The median estimate ... Get the latest Geron Corp (GERN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Find real-time GERN - Geron Corp stock quotes, company profile, news and forecasts from CNN Business.Sep 14, 2023 · Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools. Identify stocks that meet your criteria using seven unique stock screeners. Geron Corporation Announces Pricing of $198 Million Upsized Public Offering of Common Stock and Pre-Funded Warrants. (Business Wire) -22.26%. Jan-04-23 04:19PM. Geron Corporation Announces Proposed Public Offering of Common Stock. (Business Wire) +32.92%. Sep 9, 2023 · Get Geron Corp (GERN.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments Geron Corporation Common Stock (GERN) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets. The latest Geron stock prices, stock quotes, news, and GERN history to help you invest and trade smarter. Geron Corp. advanced stock charts by MarketWatch. View GERN historial stock data and compare to other stocks and exchanges.As a point of reference, over the last 10 years, the median sales growth for the stocks in the S&P 500 was 14%. Of course, different industries will have different growth rates that are considered ...Geron Corp. Annual stock financials by MarketWatch. View the latest GERN financial statements, income statements and financial ratios.jun han
Geron Corp. advanced stock charts by MarketWatch. View GERN historial stock data and compare to other stocks and exchanges. Aug 3, 2023 · by Zacks Equity Research Published on May 11,2023. Geron (GERN) delivered earnings and revenue surprises of 22.22% and 85%, respectively, for the quarter ended March 2023. Do the numbers hold ... Geron Corp. advanced stock charts by Barron's. View GERN historical stock data and compare to other stocks, and exchanges.Track Geron Corp. (GERN) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsSep 5, 2023 · Geron is working to change the course of hematologic malignancies. Geron is a late-stage biopharmaceutical company with a mission to extend and enhance the lives of patients living with hematologic malignancies. Our first-in-class telomerase inhibitor, imetelstat, has demonstrated strong evidence of disease modification in Phase 2 trials. Geron is planning to submit marketing applications for imetelstat in lower-risk MDS in the U.S. and Europe in mid-2023 and H2 2023, expecting market launches in H1 2024 and by the end of next year ...GERN Sales Forecast. Next quarter’s sales forecast for GERN is $59.00K with a range of $0.00 to $150.00K. The previous quarter’s sales results were $29.00K. GERN beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 44.58% of the time in the same period. Get Geron Corp (GERN.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsFind the latest Geron Corporation (GERN) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.boy planet ep 1 eng sub
Geron Corp. (US:GERN) has 343 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 357,031,330 shares. Largest shareholders include BlackRock Inc., Ra Capital Management, L.p., Vanguard Group Inc, Deep Track Capital, LP, TCG Crossover ... May 1, 2023 · NOTICE OF NEW DEADLINE TO FILE CLAIM OR REQUEST TO BE EXCLUDED FROM THE CLASS . To: All persons who purchased Geron Corporation (“Geron”) common stock during the period from March 19, 2018, to ... 52 Week Low Date 04/14/23. Market Cap 1.282B. Shares Out 523.37M. 10 Day Average Volume 5.60M. Dividend -. Dividend Yield -. Beta 0.81. YTD % Change 1.24.Jul 14, 2023 · Geron (GERN) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. Find real-time GERN - Geron Corp stock quotes, company profile, news and forecasts from CNN Business. Sep 14, 2023 · Sell candidate since Aug 11, 2023 Loss -18.87% PDF. No changes to the price of Geron Corporation stock on the last trading day (Thursday, 7th Sep 2023). During the last trading day the stock fluctuated 3.31% from a day low at $2.42 to a day high of $2.50. The price has risen in 6 of the last 10 days and is up by 6.99% over the past 2 weeks. This would represent a 58.06% increase in the GERN stock price. Geron Stock Prediction 2030. In 2030, the Geron stock will reach $ 11.39 if it maintains its current 10-year average growth rate. If this Geron stock prediction for 2030 materializes, GERN stock willgrow 396.44% from its current price.View the latest Geron Corp. (GERN) stock price, news, historical charts, analyst ratings and financial information from WSJ. Aug 13, 2021 · Well you can still buy a used Yugo. Kick the turds 💩 out of the way as you swirl down into the septic tank of penny stock investments. Hey buyMCD they still sell billions of happy meals plus you get a toyCheeseCracker, published August 13, 2021 What Else are GERN Traders Talking About? Other tickers frequently mentioned alongside GERN is SESN. Geron Corporation Common Stock (GERN) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. pac 12 network streaming
Stock Price Forecast. The 6 analysts offering 12-month price forecasts for Geron Corp have a median target of 5.00, with a high estimate of 6.00 and a low estimate of 4.00. The median estimate ...Back to GERN Overview About Latest Pre-Market Trades Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day.Geron Corp. Quarterly stock financials by MarketWatch. View the latest GERN financial statements, income statements and financial ratios.Geron Corp. advanced stock charts by Barron's. View GERN historical stock data and compare to other stocks, and exchanges.Stock analysis for Geron Corp (GERN:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.GERN earnings call for the period ending March 31, 2023. GERN : 2.86 (-2.05%) Geron (GERN) Reports Q1 Loss, Misses Revenue Estimates Zacks - Thu May 11, 8:15AM CDT. Geron (GERN) delivered earnings and revenue surprises of 22.22% and 85%, respectively, for the quarter ended March 2023.Fintel reports that on September 12, 2023, Goldman Sachs upgraded their outlook for Geron (NASDAQ:GERN) from Neutral to Buy . Analyst Price Forecast Suggests 110.68% Upside As of August 31, 2023 ...Geron Corporation Common Stock (GERN) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. 52 Week Low Date 04/14/23. Market Cap 1.282B. Shares Out 523.37M. 10 Day Average Volume 5.60M. Dividend -. Dividend Yield -. Beta 0.81. YTD % Change 1.24.Geron is working to change the course of hematologic malignancies. Geron is a late-stage biopharmaceutical company with a mission to extend and enhance the lives of patients living with hematologic malignancies. Our first-in-class telomerase inhibitor, imetelstat, has demonstrated strong evidence of disease modification in Phase 2 trials.Sep 8, 2023 · A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GERN shares currently have a short interest ratio of 5.0. Learn More on Geron's short interest ratio. This would represent a 58.06% increase in the GERN stock price. Geron Stock Prediction 2030. In 2030, the Geron stock will reach $ 11.39 if it maintains its current 10-year average growth rate. If this Geron stock prediction for 2030 materializes, GERN stock willgrow 396.44% from its current price. keyper systems
Apr 20, 2023 · Shares of Geron ( GERN), a clinical-stage biotech company, were up more than 30% this week before CEO John A. Scarlett's scheduled appearance at the Needham Virtual Healthcare Conference on ... What happened. Clinical-stage biopharmaceutical company Geron ( GERN 2.10%) saw its shares jump 23.4% on Wednesday. The stock, which had closed at $1.28 a share on Tuesday, opened at $1.24 on ...bankrx/iStock via Getty Images. 2023 has arrived. The year has started well, with Geron Corporation ( NASDAQ: GERN) producing superb data, data that makes imetelstat approvable after over a decade ...Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools. Identify stocks that meet your criteria using seven unique stock screeners.6:39a Enphase Energy stock price target cut to $199 from $224 at J.P. Morgan ... GERN Profile. Company Profile. Geron Corp. 919 East Hillsdale Boulevard. Suite 250. Foster City, California 94404 .Post #7,427. >>Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that the United States Food and Drug Administration (FDA) has assigned a standard review and a Prescription Drug User Fee Act (PDUFA) action date of June 16, 2024 for Geron's New Drug Application (NDA) for imetelstat for the ... GERN earnings call for the period ending March 31, 2023. GERN : 2.86 (-2.05%) Geron (GERN) Reports Q1 Loss, Misses Revenue Estimates Zacks - Thu May 11, 8:15AM CDT. Geron (GERN) delivered earnings and revenue surprises of 22.22% and 85%, respectively, for the quarter ended March 2023. What is the target price for Geron (GERN) stock? The latest price target for Geron ( NASDAQ: GERN) was reported by Wedbush on Tuesday, August 29, 2023. The analyst firm set a price target for 6.00 ... Discover historical prices for GERN stock on Yahoo Finance. View daily, weekly or monthly format back to when Geron Corporation stock was issued. Geron Corporation Announces Pricing of $198 Million Upsized Public Offering of Common Stock and Pre-Funded Warrants. (Business Wire) -22.26%. Jan-04-23 04:19PM. Geron Corporation Announces Proposed Public Offering of Common Stock. (Business Wire) +32.92%. The outlook on CCO stock is a bit mixed among analysts. However, firms like TD Securities have placed a Buy rating on the penny stock. As far as price targets go, they range between $2.50 and $3.15 among firms that have issued them. On the high end ($3.15), the forecast sits roughly 5% higher than current trading levels.Geron Corporation Common Stock (GERN) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.A high-level overview of Geron Corporation (GERN) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.The value each GERN share was expected to gain vs. the value that each GERN share actually gained. Geron ( GERN) reported Q1 2023 earnings per share (EPS) of -$0.07, beating estimates of -$0.10 by 30.00%. In the same quarter last year, Geron 's earnings per share (EPS) was -$0.09. Geron is expected to release next earnings on 08/03/2023, with ...exp enterpriseGERN Sales Forecast. Next quarter’s sales forecast for GERN is $59.00K with a range of $0.00 to $150.00K. The previous quarter’s sales results were $29.00K. GERN beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 44.58% of the time in the same period. 1 day ago · View the basic GERN option chain and compare options of Geron Corporation on Yahoo Finance. Geron Corporation Common Stock (GERN) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.As of 2023 September 11, Monday current price of GERN stock is 2.310$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception). Geron stock price has been showing a declining tendency so we believe that similar market segments were not very popular in the given period.Get the latest Geron Corp (GERN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Stock Price Forecast. The 6 analysts offering 12-month price forecasts for Geron Corp have a median target of 5.00, with a high estimate of 6.00 and a low estimate of 4.00. The median estimate ... GERN | Complete Geron Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. In a report released today, Gil Blum from Needham maintained a Buy rating on Geron ( GERN – Research Report ), with a price target of $3.00. The company’s shares closed last Friday at $2.42 ...Geron Corp. research and ratings by Barron's. View GERN revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.Geron is planning to submit marketing applications for imetelstat in lower-risk MDS in the U.S. and Europe in mid-2023 and H2 2023, expecting market launches in H1 2024 and by the end of next year ...Find real-time GERN - Geron Corp stock quotes, company profile, news and forecasts from CNN Business.Geron Corp. Quarterly stock financials by MarketWatch. View the latest GERN financial statements, income statements and financial ratios. Sep 5, 2023 · Geron is working to change the course of hematologic malignancies. Geron is a late-stage biopharmaceutical company with a mission to extend and enhance the lives of patients living with hematologic malignancies. Our first-in-class telomerase inhibitor, imetelstat, has demonstrated strong evidence of disease modification in Phase 2 trials. View GERN: Geroninvestment & stock information. Get the latest GERN: Geron detailed stock quotes, stock data, Real-Time ECN, charts, stats and more..FOSTER CITY, Calif., September 05, 2023--Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that John A. Scarlett, M.D., Geron’s Chairman and Chief Executive Officer, is scheduled to participate in a fireside chat in person at the Baird 2023 Global Healthcare Conference in New York City, NY, on ... american museum of natural history photos
Geron Corporation Announces Pricing of $198 Million Upsized Public Offering of Common Stock and Pre-Funded Warrants. (Business Wire) -22.26%. Jan-04-23 04:19PM. Geron Corporation Announces Proposed Public Offering of Common Stock. (Business Wire) +32.92%. As a point of reference, over the last 10 years, the median sales growth for the stocks in the S&P 500 was 14%. Of course, different industries will have different growth rates that are considered ...Get Geron Corp (GERN.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsSep 11, 2023 · 3 Wall Street analysts have issued 12 month price targets for Geron's stock. Their GERN share price forecasts range from $3.00 to $6.00. On average, they predict the company's share price to reach $4.50 in the next year. This suggests a possible upside of 83.7% from the stock's current price. View analysts price targets for GERN or view top ... Jul 14, 2023 · Geron (GERN) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. This would represent a 58.06% increase in the GERN stock price. Geron Stock Prediction 2030. In 2030, the Geron stock will reach $ 11.39 if it maintains its current 10-year average growth rate. If this Geron stock prediction for 2030 materializes, GERN stock willgrow 396.44% from its current price.Geron is working to change the course of hematologic malignancies. Geron is a late-stage biopharmaceutical company with a mission to extend and enhance the lives of patients living with hematologic malignancies. Our first-in-class telomerase inhibitor, imetelstat, has demonstrated strong evidence of disease modification in Phase 2 trials.This would represent a 58.06% increase in the GERN stock price. Geron Stock Prediction 2030. In 2030, the Geron stock will reach $ 11.39 if it maintains its current 10-year average growth rate. If this Geron stock prediction for 2030 materializes, GERN stock willgrow 396.44% from its current price.Find the latest Geron Corporation (GERN) stock quote, history, news and other vital information to help you with your stock trading and investing.Stock Price Forecast. The 6 analysts offering 12-month price forecasts for Geron Corp have a median target of 5.00, with a high estimate of 6.00 and a low estimate of 4.00. The median estimate ... FOSTER CITY, Calif., September 05, 2023--Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that John A. Scarlett, M.D., Geron’s Chairman and Chief Executive Officer, is scheduled to participate in a fireside chat in person at the Baird 2023 Global Healthcare Conference in New York City, NY, on ...columbia daily herald
Real time Geron (GERN) stock price quote, stock graph, news & analysis. GERN earnings call for the period ending March 31, 2023. GERN : 2.43 (-0.82%) Geron (GERN) Reports Q1 Loss, Misses Revenue Estimates Zacks - Thu May 11, 8:15AM CDT. Geron (GERN) delivered earnings and revenue surprises of 22.22% and 85%, respectively, for the quarter ended March 2023.GERN stock closed at $2.34 and is up $0.12 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. GERN has a roughly average overall score of 45 meaning the stock holds a better value than 45% of stocks at its current price.Geron Corp. advanced stock charts by MarketWatch. View GERN historial stock data and compare to other stocks and exchanges.Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools. Identify stocks that meet your criteria using seven unique stock screeners.